This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

KB9520

Karo Bio

Drug Names(s): KB9520, ERbeta agonist

Description: KB9520 targets the estrogen receptor beta (ERbeta).

The compound has shown efficacy in different forms of cancer. In these disease models, the treatment has demonstrated to significantly reduce tumor size due to the substance’s anti-proliferative and pro-apoptotic effects.


KB9520 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug